Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

BMS-247550 in metastatic breast cancer

Dec. 12, 2003

Safety and clinical efficacy of GW-572016 in advanced breast cancer

Dec. 12, 2003

Disease stabilization in phase II multiple myeloma study of Panzem

Dec. 12, 2003

Vion enters research and option agreement for novel anticancer compounds

Dec. 12, 2003

Novel inhibitor of Stat3 activation with activity against hematological malignancies

Dec. 11, 2003

Antitumor efficacy of Bay-59-8862 in metastatic breast cancer

Dec. 11, 2003

Improved survival with RSR-13 plus WBRT in breast cancer patients with brain metastases

Dec. 11, 2003

Antitumor activity of E-7070 in metastatic breast cancer

Dec. 11, 2003

New phase II trials to evaluate KOS-862 for various cancers

Dec. 11, 2003

Sugen identifies potential surrogate markers for SU-11248 activity

Dec. 11, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...